
Matinas BioPharma Holdings, Inc.
AMEX:MTNB
0.2346 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 7.284 | 4.787 | 6.83 | 21.03 | 12.432 | 22.17 | 12.447 | 7.307 | 4.105 | 3.227 | 2.591 | 10.84 | 0.424 |
Short Term Investments
| 0 | 8.969 | 21.933 | 28.592 | 46.247 | 5.605 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 7.284 | 13.756 | 28.763 | 49.622 | 58.679 | 27.775 | 12.447 | 7.307 | 4.105 | 3.227 | 2.591 | 10.84 | 0.424 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.741 | 1.787 | 11.488 | 1.371 | 2.876 | 2.148 | 0.639 | 0.657 | 0.46 | 0.332 | 0.214 | 0.084 | 0 |
Total Current Assets
| 8.025 | 15.543 | 34.532 | 50.993 | 61.555 | 29.923 | 13.085 | 7.964 | 4.565 | 3.559 | 2.805 | 10.925 | 0.424 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 1.688 | 5.008 | 5.734 | 5.779 | 4.859 | 5.628 | 2.043 | 1.57 | 0.356 | 0.378 | 0.34 | 0.093 | 0 |
Goodwill
| 0 | 1.336 | 1.336 | 1.336 | 1.336 | 1.336 | 1.336 | 1.336 | 1.336 | 1.336 | 0 | 0 | 0 |
Intangible Assets
| 2.26 | 3.017 | 3.017 | 3.017 | 3.017 | 3.017 | 3.017 | 3.017 | 3.017 | 3.017 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 2.26 | 4.353 | 4.353 | 4.354 | 4.354 | 4.353 | 4.354 | 4.354 | 4.354 | 4.354 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 34.047 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.668 | 0.2 | -34.047 | 0.2 | 0.2 | 0.336 | 0.461 | 0.536 | 0.541 | 0.115 | 0.216 | 0.316 | 0 |
Total Non-Current Assets
| 4.616 | 9.561 | 10.287 | 10.333 | 9.412 | 10.317 | 6.858 | 6.46 | 5.251 | 4.847 | 0.556 | 0.409 | 0 |
Total Assets
| 12.641 | 25.104 | 44.819 | 61.326 | 70.967 | 40.24 | 19.943 | 14.424 | 9.816 | 8.406 | 3.361 | 11.334 | 0.424 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 0.095 | 0.514 | 0.618 | 0.937 | 0.35 | 0.679 | 0.296 | 0.583 | 0.476 | 0.498 | 0.271 | 0.397 | 0.06 |
Short Term Debt
| 0.766 | 0.661 | 1.138 | 0.56 | 0.422 | 0.478 | 0.283 | 0.197 | 0.128 | 0.011 | 0.044 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0.721 | 0.932 | 0.643 | 0.1 | -0.083 | 0.03 | 0 | 0.608 | 0.758 | 0 | 0 |
Other Current Liabilities
| 1.805 | 1.447 | 2.53 | 2.852 | 2.795 | 1.84 | 2.261 | 0.959 | 0.841 | 0.619 | 0.803 | 0.462 | 0.024 |
Total Current Liabilities
| 2.666 | 2.622 | 4.286 | 4.349 | 3.568 | 3.097 | 2.84 | 2.225 | 1.445 | 1.129 | 1.118 | 0.859 | 0.084 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 0 | 2.895 | 3.555 | 4,147.151 | 3.328 | 3,753.824 | 0.108 | 0.068 | 0.016 | 0 | 0.015 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | -0.341 | -0.341 | -0.341 | -0.341 | -0.108 | -0.247 | -1.205 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0.257 | 0.341 | 0.341 | 0.341 | 0.341 | 0.341 | 0.341 | 0.848 | 1.205 | 1.205 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 2.128 | 0 | 0 | -4,143.008 | 0 | -3,750.074 | 0.513 | 0.601 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 2.385 | 3.236 | 3.896 | 4.484 | 3.669 | 4.092 | 0.962 | 1.517 | 1.222 | 1.205 | 0.015 | 0 | 0 |
Total Liabilities
| 5.051 | 5.858 | 8.182 | 8.833 | 7.237 | 7.189 | 3.802 | 3.742 | 2.666 | 2.334 | 1.134 | 0.859 | 0.084 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 3.798 | 3.986 | 9.78 | 5.717 | 6.086 | 0 | 0 | 0 | 0.457 |
Common Stock
| 0.001 | 0.022 | 0.022 | 0.022 | 0.02 | 0.016 | 0.011 | 0.009 | 0.006 | 0.006 | 0.003 | 0.003 | 0.001 |
Retained Earnings
| -199.824 | -175.573 | -152.631 | -131.634 | -107.507 | -84.378 | -65.945 | -51.275 | -35.18 | -23.187 | -14.052 | -3.831 | -0.118 |
Accumulated Other Comprehensive Income/Loss
| 0 | -0.221 | -0.824 | -0.145 | 0.228 | -0.001 | -0.439 | -0 | 0 | -0 | -0 | 0 | 0 |
Other Total Stockholders Equity
| 207.413 | 195.018 | 190.07 | 184.251 | 167.192 | 113.428 | 72.295 | 56.23 | 36.238 | 29.254 | 16.276 | 14.302 | 0 |
Total Shareholders Equity
| 7.59 | 19.246 | 36.637 | 52.493 | 63.731 | 33.051 | 16.142 | 10.682 | 7.15 | 6.072 | 2.228 | 10.475 | 0.34 |
Total Equity
| 7.59 | 19.246 | 36.637 | 52.493 | 63.731 | 33.051 | 16.142 | 10.682 | 7.15 | 6.072 | 2.228 | 10.475 | 0.34 |
Total Liabilities & Shareholders Equity
| 12.641 | 25.104 | 44.819 | 61.326 | 70.967 | 40.24 | 19.943 | 14.424 | 9.816 | 8.406 | 3.361 | 11.334 | 0 |